Mark Hollywood

Direttore Tecnico/Scientifico/R&S presso ZYMEWORKS INC.

55 anni

Health Technology

Commercial Services

Consumer Services

Profilo

Mark Hollywood is currently the EVP & Head-Technical & Manufacturing Operations at Zymeworks BC, Inc. and the EVP, Head-Technical & Manufacturing Operations at Zymeworks, Inc. Previously, he worked as the Director-Quality Assurance & Quality Control at CellCyte Genetics Corp.
and as the Vice President & Head-ZymoGenetics at Bristol Myers Squibb Co. He obtained his undergraduate degree from Western Illinois University.

Posizioni attive di Mark Hollywood

Società	Posizione	Inizio
ZYMEWORKS INC.	Direttore Tecnico/Scientifico/R&S	01/01/2019
Zymeworks BC, Inc. Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.	Direttore Tecnico/Scientifico/R&S	30/04/2019

Tutte le posizioni attive di Mark Hollywood

Precedenti posizioni note di Mark Hollywood

Società	Posizione	Fine
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	01/01/2019
CELLCYTE GENETICS CORPORATION	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Mark Hollywood

Formazione di Mark Hollywood

Western Illinois University

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Mark Hollywood

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
BRISTOL-MYERS SQUIBB COMPANY	Health Technology
ZYMEWORKS INC.	Health Technology

Aziende private	2
CellCyte Genetics Corp. CellCyte Genetics Corp. Miscellaneous Commercial ServicesCommercial Services CellCyte Genetics Corp. engaged in the discovery and development of stem cell therapeutic products. It enabled therapeutic advancements to safely deliver stem cells through the patient's own circulatory or vascular system directly into a specific diseased, damaged or dying organ. The company was founded on March 9, 2004 and was headquartered in Freeland, WA.	Commercial Services
Zymeworks BC, Inc. Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.	Health Technology

Aziende private